← Back to Clinical Trials
Recruiting NCT07655271

NCT07655271 Evaluation of Pain, Upper Extremity Function, and Social Appearance Anxiety in Adults With Obstetric Brachial Plexus Palsy Who Underwent Shoulder Tendon Transfer Surgery

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07655271
Status Recruiting
Phase
Sponsor Biruni University
Condition Brachial Plexus Birth Palsy
Study Type OBSERVATIONAL
Enrollment 80 participants
Start Date 2026-07-01
Primary Completion 2026-12-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 40 Years
Study Type OBSERVATIONAL
Interventions
Clinical Assessment Battery

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 80 participants in total. It began in 2026-07-01 with a primary completion date of 2026-12-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This observational study aims to evaluate pain and upper extremity function in adults with obstetric brachial plexus palsy who underwent shoulder tendon transfer surgery using the Modified Hoffer technique during childhood. Data on the long-term clinical outcomes of this surgical procedure in adulthood are limited. Participants with obstetric brachial plexus palsy and healthy age-matched individuals will be assessed in a single session. The evaluations will include pain, range of motion, muscle strength, upper extremity functional status, social appearance anxiety, and role performance. The study aims to describe the clinical profile of adults with obstetric brachial plexus palsy after Modified Hoffer tendon transfer and compare their outcomes with healthy peers.

Eligibility Criteria

Inclusion and Exclusion Criteria Inclusion Criteria for Individuals With Brachial Plexus Birth Palsy: * Being between 18 and 40 years of age. * Having a diagnosis of unilateral brachial plexus birth palsy. * Having undergone shoulder tendon transfer surgery using the Modified Hoffer Technique. * Having at least 5 years elapsed since the last surgery. * Having a cognitive and communication level sufficient to comply with the assessment process. * Agreeing to participate voluntarily in the study and signing the informed consent form. Inclusion Criteria for Healthy Individuals: * Being between 18 and 40 years of age. * Having no history of upper extremity-related surgery within the last 5 years. * Having a cognitive and communication level sufficient to comply with the assessment process. * Agreeing to participate voluntarily in the study and signing the informed consent form. Exclusion Criteria for All Participants: * Having a neurological disease. * Having another orthopedic problem or a history of trauma in the affected upper extremity. * Having a history of systemic disease requiring an acute attack or hospitalization within the last 3 months. * Pregnancy or being less than 6 months postpartum.

Frequently Asked Questions

Who can join the NCT07655271 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 40 Years, studying Brachial Plexus Birth Palsy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07655271 currently recruiting?

Yes, NCT07655271 is actively recruiting participants. Visit ClinicalTrials.gov or contact Biruni University to inquire about joining.

Where is the NCT07655271 trial being conducted?

This trial is being conducted at Istanbul, Turkey (Türkiye).

Who is sponsoring the NCT07655271 clinical trial?

NCT07655271 is sponsored by Biruni University. The trial plans to enroll 80 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology